Home / Funding directory / MRFF 2023 TTRA Cardiovascular Disease and Diabetes Drugs and Devices
Closed
MRFF 2023 TTRA Cardiovascular Disease and Diabetes Drugs and Devices
Eligible entities seeking to accelerate into practice promising drugs and devices that reduce the burden of cardiovascular disease and complications of diabetes..
This listing is closed. It is retained for reference and is not presented as a current application opportunity. Check the official source for later rounds.
Funding and availability
A grant of up to $15 million for topic A and $13.5 million for topic B, to cover up to 100% of eligible expenditure.
Closed in the official listing; check for future rounds
Who it is for
Applicant scope is summarised from the official listing. Additional legal-entity, location, project, expenditure, ownership and application conditions can apply. Full eligibility guidelines have not been reviewed for this entry.
Application process
Open the official listing, follow its administering-provider link and confirm the current guidelines and application process.
